0

PF-04217903

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP956906937
CAS956906-93-7
MDL NumberMFCD17392584
Molecular Weight468.49
InChI KeyHBEMHKVWZJTVOC-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: ≥5 mg/mL (warmed)
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Hgf/Met Activation Mediates Resistance to BRAF Inhibition in Murine Anaplastic Thyroid Cancers

Jeffrey A Knauf, Kathleen A Luckett, Kuen-Yuan Chen, Francesca Voza, Nicholas D Socci, Ronald Ghossein, James A Fagin

J Clin Invest. 2018 Aug 31;128(9):4086-4097.

PMID: 29990309

1

Insight Into the Key Features for Ligand Binding in Y1230 Mutated c-Met Kinase Domain by Molecular Dynamics Simulations

Libo Yan, Li Zhang, Yanmin Zhang, Xin Qiao, Jing Pan, Haichun Liu, Shuai Lu, Bingren Xiang, Tao Lu, Haoliang Yuan

J Biomol Struct Dyn. 2018 Jun;36(8):2015-2031.

PMID: 28599617

1

Sensitivity of Selected Human Tumor Models to PF-04217903, a Novel Selective c-Met Kinase Inhibitor

Helen Y Zou, Qiuhua Li, Joseph H Lee, Maria E Arango, Kristina Burgess, Ming Qiu, Lars D Engstrom, Shinji Yamazaki, Max Parker, Sergei Timofeevski, Jingrong Jean Cui, Michele McTigue, Gerrit Los, Steven L Bender, etc.

Mol Cancer Ther. 2012 Apr;11(4):1036-47.

PMID: 22389468

1

The Study of Endogenous Hepatocyte Growth Factor in the Pathogenesis of Intracranial Aneurysms

L-L Yu, Y-J Liu, Z-H Wang, L Shi, L-X Liu

Eur Rev Med Pharmacol Sci. 2017 Feb;21(4):795-803.

PMID: 28272703

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode